Med. praxi. 2016;13(1):43-46 | DOI: 10.36290/med.2016.009

Neuromyelitis optica (Devic’s disease) - a rare demyelinating disease

MUDr.Petra Nytrová, MUDr.Jana Kopecká, MUDr.Dana Horáková
Neurologická klinika a Centrum klinických neurověd, Univerzita Karlova v Praze,
1 . lékařská fakulta a Všeobecná fakultní nemocnice v Praze

Neuromyelitis optica, also known as Devic‘s disease is an autoimmune disease of the central nervous system characterized by attacks

of optic neuritis and myelitis. After the discovery of disease specific antibodies against aquaporin 4 (AQP4-IgG/NMO-IgG)

the spectrum of clinical symptoms of this disease was broadened. In particular, these symptoms include singultus, vomiting,

cranial nerve palsy and disorders of osmotic balance in hypothalamus involvement. Determination of AQP4-IgG in serum along

with magnetic resonance imaging of the brain and spinal cord are indispensable in diagnosis of this disease at the time of the

first manifestation of the disease. On the other hand, AQP4 negativity does not exclude the diagnosis of NMO-IgG, which then

requires a broader differential diagnosis in clinical practice.

Keywords: neuromyelitis optica, AQP4-IgG, longitudinally extensive transverse myelitis

Published: March 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Nytrová P, Kopecká J, Horáková D. Neuromyelitis optica (Devic’s disease) - a rare demyelinating disease. Med. praxi. 2016;13(1):43-46. doi: 10.36290/med.2016.009.
Download citation

References

  1. Wingerchuk DM. Diagnosis and treatment of neuromyelitis optica. Neurologist. 2007; 13: 2-11. Go to original source... Go to PubMed...
  2. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology. 1999; 53: 1107-1114. Go to original source... Go to PubMed...
  3. Nytrová P, Kleinová P, Preiningerová Lízrová J, Král V, Hinďoš M, Vaněčková M, Havrdová E, Horáková D. Neuromyelitis optica a poruchy jejího širšího spektra - retrospektivní analýza klinických a paraklinických nálezů. Cesk Slov Neurol N. 2015; 78/111(1): 72-77. Go to original source...
  4. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004; 364: 2106-2112. Go to original source... Go to PubMed...
  5. Waters P, Jarius S, Littleton E, Leite MI, Jacob S, Gray B, Geraldes R, Vale T, Jacob A, Palace J, Maxwell S, Beeson D, Vincent A. Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis. Archives of neurology. 2008; 65: 913-919. Go to original source... Go to PubMed...
  6. Marrie RA, Gryba C. The incidence and prevalence of neuromyelitis optica: a systematic review. International journal of MS care. 2013; 15: 113-118. Go to original source... Go to PubMed...
  7. Uzawa A, Mori M, Kuwabara S. Neuromyelitis optica: concept, immunology and treatment. Journal of clinical neuroscience: official journal of the Neurosurgical Society of Australasia. 2014; 21: 12-21. Go to original source... Go to PubMed...
  8. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. The Journal of experimental medicine. 2005; 202: 473-477. Go to original source... Go to PubMed...
  9. Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, Trebst C, Weinshenker B, Wingerchuk D, Parisi JE, Lassmann H. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain: a journal of neurology. 2002; 125: 1450-1461. Go to original source... Go to PubMed...
  10. Lucchinetti CF, Guo Y, Popescu BF, Fujihara K, Itoyama Y, Misu T. The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica. Brain pathology. 2014; 24: 83-97. Go to original source... Go to PubMed...
  11. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. The Lancet Neurology. 2007; 6: 805-815. Go to original source... Go to PubMed...
  12. Pittock SJ, Lennon VA, de Seze J, Vermersch P, Homburger HA, Wingerchuk DM, Lucchinetti CF, Zephir H, Moder K, Weinshenker BG. Neuromyelitis optica and non organ-specific autoimmunity. Archives of neurology. 2008; 65: 78-83. Go to original source... Go to PubMed...
  13. Tackley G, Kuker W, Palace J. Magnetic resonance imaging in neuromyelitis optica. Multiple sclerosis. 2014; May 14. pii: 1352458514531087 v tisku. Go to original source... Go to PubMed...




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.